Dr. Szymon Hryhorowicz is a graduate of the interdisciplinary doctoral program at the NanoBioMedical Center, Adam Mickiewicz University in Poznań. Since 2014, he has been affiliated with the Institute of Human Genetics of the Polish Academy of Sciences, where he serves as an Assistant Professor at the IGC PAN Innovative Medical Center.
Since late 2025, he has been the Head of the Spatial Multiomics Laboratory, focusing on spatial single-cell transcriptomics. Dr. Hryhorowicz has extensive experience in experimental design, workflow optimization, and protocol development to ensure high-quality, reproducible spatial datasets. He also possesses broad expertise in next-generation sequencing (NGS) technologies, significantly strengthening the multiomics capabilities of his laboratory.
Beyond his technical expertise, Dr. Hryhorowicz actively shapes the laboratory’s scientific vision — implementing innovative methodologies, overseeing quality and compliance standards, and fostering collaborations to advance research in spatial biology.
He has completed several research internships at leading international institutions, including the Berlin Institute for Medical Systems Biology (MDC-BIMSB) at the Max Delbrück Center (Thomas Conrad lab), where he gained a strong foundation in cutting-edge spatial multiomics techniques. His international experience also includes a stint at the Translational Neuropsychopharmacology Laboratory, Neuroscience Institute, Miguel Hernández University–CSIC in San Juan de Alicante, Spain (Jorge Manzanares lab), and at the China National Research Institute of Food and Fermentation Industries in Beijing.
His research interests focus on inflammatory bowel diseases, with particular emphasis on the role of the endocannabinoid system. His work investigates the molecular mechanisms regulating CB1 and CB2 cannabinoid receptor activation in intestinal mucosal inflammation, as well as gene expression profiles involved in cannabinoid metabolism.
